Paper Review Records
全部论文审稿周期
12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
52
天
Pharmacological enhancement of O-GlcNAcylation attenuates lung ischemia-reperfusion injury
作者
Yang Jin; Yu Fu; Nan Zhang; Xuemei Jiang; Jiameng Gao; Zhiyuan Zhang; Xiaotong Huang; Maojun Zhou; Chang Chen; Zongmei Wen展开收起
作者单位
Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China展开收起
287
天
Belumosudil improves experimental pulmonary fibrosis via the ROCK2/Smad3/CTGF pathway
作者
Dexin Kong; Guanghua Zhang; Zhonghong Jiang; Wanglin Jiang展开收起
作者单位
School of Pharmacy, Shandong Medical and Pharmaceutical University, Yantai, 264003, PR China; Yantai Center for Food and Drug Control, Yantai, 264011, PR China; West China School of Pharmacy, Sichuan University, Chengdu, 640041, PR China展开收起
57
天
Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers
作者
Maneesh Kumar Maddirevula; Muhasaparur G. Rajanandh; Boman Wesley展开收起
作者单位
Department of Pharmacy Practice, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalapattu, Tamil Nadu, 603203, India; Department of Pharmacy Practice, Mahathi College of Pharmacy, Madanapalle, Andhra Pradesh, 517319, India; Department of Pulmonary Medicine, Arogyavarm Medical Center, Madanapalle, Andhra Pradesh, 517319, India展开收起
113
天
m6A reader IGF2BP2 mediates airway remodeling by stabilizing Dixdc1 in asthma pathogenesis
作者
Xiao-Mang Li; Bi-Wen Mo; Yan Gao; Yun-Xiang Chen; Bo Xiao; Yue Gu; Miao-Miao Liang; Hui-Min Li展开收起
作者单位
Guilin Medical University, Guilin, 541004, Guangxi, China; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China; Respiratory Disease Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, 541004, Guangxi, China展开收起
135
天
Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis
作者
Karina Kleinfelder; Anca Manuela Hristodor; Giorgio Centin; Antonella Casiraghi; Paola Minghetti; Emily Pintani; Marina Bertini; Claudio Sorio; Paola Melotti展开收起
作者单位
Department of Medicine, Division of General Pathology, Cystic Fibrosis Laboratory “D. Lissandrini”, University of Verona, Verona, 37134, Italy; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, Verona, 37126, Italy; Department of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milan, 20133, Italy展开收起
47
天
Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers
作者
Jens M. Hohlfeld; Meike Müller; Philipp Badorrek; Laurent B. Nicolas; Oliver Vit; William G. Darby; Judith Field; Michael Larbig展开收起
作者单位
Division of Airway Research, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Nikolai-Fuchs-Str. 1, Hannover, 30625, Germany; Department of Respiratory Medicine and Infectious Disease, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany; Member of the German Center for Lung Research (DZL), BREATH, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany; Clinical Pharmacology and Pharmacometrics, CSL Behring AG, Wankdorfstrasse 10, Bern, 3014, Switzerland; Clinical Development, CSL Behring AG, Wankdorfstrasse 10, Bern, 3014, Switzerland; CSL Innovation, 30 Flemington, Parkville, 3010, Australia展开收起
FAQ
PULMONARY PHARMACOLOGY & THERAPEUTICS审稿要多久?
截至2026-11-19,CrushSCI 收录了 PULMONARY PHARMACOLOGY & THERAPEUTICS 的 12 篇完整审稿记录。最快一篇从收稿到录用用了 47 天(Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers,2026-05-19 收稿,2026-07-05 录用),最慢一篇用了 351 天;平均 160.5 天,中位数 124 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
